Apr 282020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Gemini Therapeutics, a clinical-stage precision medicine company developing innovative treatments for dry Age-related Macular Degeneration and linked ocular disorders, today announced the appointment of David Lubner to its Board as an independent member. “David is an accomplished finance executive, with more than 20 years of wide-ranging ...

Gemini Therapeutics appoints David Lubner to its Board as Independent Director

Gemini Therapeutics appoints David Lubner to its Board as Independent Director

From:: Gemini Therapeutics appoints David Lubner to its Board as Independent Director

Sorry, the comment form is closed at this time.